# BORGWARNER INC. (BWA) · Edgar & Edgarette company card

> Borgwarner (BWA) grew revenue 1.6% in FY2025 to $14.3 billion, operating margin 3.7% against a 6.9% median for motor vehicle parts & accessories, equity 39.5% of assets, and dividend per share up 1 year running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 908255 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/BWA) · [JSON](https://www.pops4.com/boards/company/BWA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $14.3B |
| Revenue growth, 1 year | 1.6% |
| Revenue growth per year | 4.9% |
| Operating margin | 3.7% (prior year 3.9%) |
| Net margin | 2.3% |
| Operating cash flow | — |
| Capital spending | $469M |
| Free cash flow | — |
| Cash | $2.3B |
| Long-term debt | $3.9B |
| Total assets | $13.8B |
| Total equity | $5.4B |
| Equity ÷ assets | 39.5% |
| Return on equity | 6.2% |
| Dividend per share | $0.56 |
| Dividend years rising | 1 |

## Readings, computed from those figures

- Altman Z: 4.19 (safe zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: New ship · no warning signs

## Edgarette's reading

Exposure: revenue $14.3B (FY2025), total debt $3.9B. Experience: revenue up 1.6% on the year, up 4.9% a year over 4 years; operating margin 3.7%, down from 3.9%. Soundness: equity 39.5% of assets, return on equity 6.2%, payout 35.5% of profit, dividend per share up 1 year running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $13.1B and $15.5B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $12.2B to $16.6B. A statistical range, not company guidance. Against peers (24 filers, $50M+ revenue, motor vehicle parts & accessories): operating margin 3.7% against a 6.9% median; growth 1.6% against 2.7%.

Range logged 2026-09-29, receipt 062d9790544c1dac, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-07-31 ([filing](https://www.sec.gov/Archives/edgar/data/908255/000090825526000045/0000908255-26-000045-index.htm))

## Recent filings

- 10-Q · filed 2026-10-29 · [filing](https://www.sec.gov/Archives/edgar/data/908255/000090825526000062/0000908255-26-000062-index.htm)
- 8-K · filed 2026-10-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/908255/000090825526000060/0000908255-26-000060-index.htm)
- 8-K · filed 2026-09-04 · 7.01 Regulation FD Disclosure · [filing](https://www.sec.gov/Archives/edgar/data/908255/000110465926105519/0001104659-26-105519-index.htm)
- 8-K · filed 2026-08-10 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/908255/000090825526000054/0000908255-26-000054-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/908255/000090825526000051/0000908255-26-000051-index.htm)
- 8-K · filed 2026-08-05 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/908255/000090825526000049/0000908255-26-000049-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000908255.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=908255

## Cite

POPS4, Edgar & Edgarette: BORGWARNER INC. (BWA) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/BWA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.